Folgen
Michael J Wedemeyer
Michael J Wedemeyer
Postdoctoral Researcher at UT Health San Antonio
Bestätigte E-Mail-Adresse bei uthscsa.edu
Titel
Zitiert von
Zitiert von
Jahr
Heterogeneous stock rats: a model to study the genetics of despair‐like behavior in adolescence
K Holl, H He, M Wedemeyer, L Clopton, S Wert, JK Meckes, R Cheng, ...
Genes, Brain and Behavior 17 (2), 139-148, 2018
322018
Calcium-oligochitosan-pectin microcarrier for colonic drug delivery
S Stealey, X Guo, R Majewski, A Dyble, K Lehman, M Wedemeyer, ...
Pharmaceutical Development and Technology 25 (2), 260-265, 2020
242020
The chemokine X-factor: Structure-function analysis of the CXC motif at CXCR4 and ACKR3
MJ Wedemeyer, SA Mahn, AE Getschman, KS Crawford, FC Peterson, ...
Journal of Biological Chemistry 295 (40), 13927-13939, 2020
192020
Modeling the complete chemokine–receptor interaction
MJ Wedemeyer, BK Mueller, BJ Bender, J Meiler, BF Volkman
Methods in cell biology 149, 289-314, 2019
122019
Design of artificial red blood cells using polymeric hydrogel microcapsules: hydrogel stability improvement and polymer selection
W Zhang, MJ Bissen, ES Savela, JN Clausen, SJ Fredricks, X Guo, ...
The International journal of artificial organs 39 (10), 518-523, 2016
102016
The non-ELR CXC chemokine encoded by human cytomegalovirus UL146 genotype 5 contains a C-terminal β-hairpin and induces neutrophil migration as a selective CXCR2 agonist
C Berg, MJ Wedemeyer, M Melynis, RR Schlimgen, LH Hansen, ...
PLoS Pathogens 18 (3), e1010355, 2022
52022
Comparative modeling and docking of chemokine-receptor interactions with Rosetta
MJ Wedemeyer, BK Mueller, BJ Bender, J Meiler, BF Volkman
Biochemical and biophysical research communications 528 (2), 389-397, 2020
42020
Mechanistic insight into the suppression of polyglutamine aggregation by SRCP1
HN Haver, M Wedemeyer, E Butcher, FC Peterson, BF Volkman, ...
ACS chemical biology 18 (3), 549-560, 2023
32023
14-3-3γ mediates the long-term inhibition of peripheral kappa opioid receptor antinociceptive signaling by norbinaltorphimine
MJ Wedemeyer, EM Jennings, HR Smith, TS Chavera, RJ Jamshidi, ...
Neuropharmacology 220, 109251, 2022
22022
Long-term Kappa Opioid Receptor Inhibition by Norbinaltorphimine and 14-3-3γ
MJ Wedemeyer, E Jennings, HR Smith, T Chaver, R Jamshidi, K Berg, ...
Journal of Pharmacology and Experimental Therapeutics 389 (S3), 2024
2024
Insurmountable Antagonism by Buprenorphine at Human Mu Opioid Receptors
M Wedemeyer, K Berg, W Clarke
Journal of Pharmacology and Experimental Therapeutics 385 (S3), 2023
2023
Characterization of Buprenorphine Antagonism at Human Mu Opioid Receptors
MJ Wedemeyer, KA Berg, WP Clarke
The FASEB Journal 36, 2022
2022
Unraveling the Selectively Promiscuous Chemokine-Receptor Interaction Network
MJ Wedemeyer
The Medical College of Wisconsin, 2020
2020
ENGINEERING ORTHOGONALITY INTO THE CHEMOKINE-GPCR INTERFACE USING ROSETTA
M Wedemeyer, BK Mueller, J Meiler, B Volkman
PROTEIN SCIENCE 28, 159-160, 2019
2019
Heterogeneous Stock Rats: A Model To Study The Genetics Of Despair And Fluoxetine Resistance in Adolescence
LCS Woods, K Holl, H He, M Wedemeyer, L Clopton, S Wert, J Meckes, ...
The FASEB Journal 31, 1058.10-1058.10, 2017
2017
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–15